EQ-5D–Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review-Reference-Cited by-同舟云学术

EQ-5D–Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review

Published:2020-07 Issue:7 Volume:23 Page:953-968
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Golicki Dominik,Jaśkowiak Katarzyna,Wójcik Alicja,Młyńczak Katarzyna,Dobrowolska Iwona,Gawrońska Andżelika,Basak Grzegorz,Snarski Emilian,Hołownia-Voloskova Malwina,Jakubczyk Michał,Niewada Maciej

Funder

EuroQol Research Foundation

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference122 articles.

1. Time to entry for new cancer medicines: from European Union-wide marketing authorization to patient access in Belgium, Estonia, Scotland, and Sweden;Ferrario;Value Health,2018

2. A tale of two thresholds: a framework for prioritization within the Cancer Drugs Fund;Leigh;Value Health,2016

3. Advances in cancer therapeutics and patient access to new drugs;Dranitsaris;Pharmacoeconomics,2011

4. Methods for the Economic Evaluation of Health Care Programmes;Drummond,2015

5. Measuring and Valuing Health Benefits for Economic Evaluation;Brazier,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of health state utility values for older people with acute myeloid leukaemia;Quality of Life Research;2024-08-22

2. Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia;Blood Advances;2024-05-31

3. Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies;Blood Advances;2024-05-14

4. Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations;PharmacoEconomics;2024-03-29

5. Ibrutinib Plus RCHOP versus RCHOP Only in Young Patients with Activated B-Cell-like Diffuse Large B-Cell Lymphoma (ABC-DLBCL): A Cost-Effectiveness Analysis;Current Oncology;2023-12-15